What is the recommended treatment for insomnia in children using hydroxyzine (antihistamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine for Pediatric Insomnia

Hydroxyzine is not recommended as a treatment for insomnia in children due to limited evidence supporting its use, and behavioral interventions followed by melatonin should be prioritized instead.

Treatment Algorithm for Pediatric Insomnia

First-Line: Behavioral Interventions (Always Start Here)

  • Establish consistent bedtime routines with fixed sleep and wake times, which can reduce initial insomnia with an effect size of 0.67 in children 1
  • Implement visual schedules to help children understand bedtime expectations, particularly effective for those who prefer routine and sameness 2
  • Use bedtime fading by temporarily moving bedtime later to match natural sleep onset, then gradually shift earlier in 15-30 minute increments 2
  • Provide hands-on parent education about sleep hygiene, proper sleep-onset associations, and consistent limit-setting 2
  • Maintain sleep diaries to objectively track sleep onset, duration, and night wakings 1

Second-Line: Melatonin (If Behavioral Interventions Fail After 2-4 Weeks)

  • Melatonin has the strongest evidence base for treating pediatric insomnia and is the safest pharmacological choice for children with neurodevelopmental disorders 3, 1
  • Start with 1 mg administered 30-60 minutes before bedtime in children over 2 years old 1, 4
  • Titrate by 1 mg every 2 weeks if ineffective, up to a maximum of 5-6 mg 1
  • Melatonin produces an effect size of 1.7 with a mean reduction in sleep onset latency of 60 minutes 1
  • Can reduce sleep latency by 16-42 minutes and is generally well-tolerated with mild side effects 1

Why Hydroxyzine Is Not Recommended

  • Antihistamine agents such as hydroxyzine are the most widely prescribed sedatives in pediatric practice, but evidence supporting their use is still limited 5
  • No medications are approved by the US Food and Drug Administration for pediatric insomnia 3
  • The evidence base for antihistamines in treating childhood insomnia remains insufficient compared to melatonin 5, 6

Follow-Up and Monitoring

  • Schedule follow-up within 2-4 weeks after initiating any intervention 1, 2
  • Expect to see benefits and improvements within 4 weeks 3
  • Monitor for treatment-emergent daytime sleepiness, which can impair school performance and requires dose adjustment 1
  • Reassess diagnosis and consider alternative approaches if no benefit is seen within 4 weeks 1

When to Refer to Sleep Specialist

  • Insomnia not improving with initial interventions 3, 2
  • Particularly severe insomnia causing significant daytime impairment or placing the child at risk for harm while awake at night 3
  • Suspected underlying primary sleep disorders (sleep apnea, restless legs syndrome, periodic limb movements, parasomnias) 3, 2
  • Children taking multiple medications for sleep when initially assessed 3

Critical Pitfalls to Avoid

  • Do not start with medication when behavioral interventions have strong evidence and avoid medication side effects 2
  • Do not implement behavioral strategies without adequate parent education and support, as success depends on proper implementation 2
  • Benzodiazepines are not recommended for chronic insomnia in children due to risk of disinhibition and behavioral side effects 2

References

Guideline

Management of Insomnia in Teenagers with ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Sleep Anxiety in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities.

Journal of child psychology and psychiatry, and allied disciplines, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.